Please login to the form below

Not currently logged in
Email:
Password:

compulsory licenses

This page shows the latest compulsory licenses news and features for those working in and with pharma, biotech and healthcare.

BMS says it defends Sprycel patent in India

BMS says it defends Sprycel patent in India

BMS says it defends Sprycel patent in India. Blocks attempts to issue compulsory license for leukaemia drug. ... Bristol-Myers Squibb (BMS) has said it has blocked an attempt to issue a compulsory license for its cancer drug Sprycel in India for the

Latest news

  • Boehringer to restructure in Southern Europe Boehringer to restructure in Southern Europe

    Part of this reluctance to expand is down to the patent situation in India, which has seen compulsory licenses effectively overturn patents for several major drugs.

  • Chinese compulsory licensing law comes into effect Chinese compulsory licensing law comes into effect

    Chinese compulsory licensing law comes into effect. Will allow production of generic drugs for domestic and international markets. ... China's State Intellectual Property Office can now issue compulsory licenses to eligible companies, giving them the

  • Ecuador overrides 2,000 pharma patents

    In a statement, President Rafael Correa said that access to medicine is a "human right" and that he intended to seek "compulsory licenses" to acquire medications considered "indispensable". ... Under current World Trade Organisation (WTO) rules,

  • Thailand imports generic Plavix from India

    Thailand has already angered Western pharmaceutical companies by issuing compulsory licenses, which temporarily suspend patent protections for branded medications. ... The Thai government has so far approved compulsory licenses for Plavix and two patent

  • Week-in-Review Editorial: 18 to 24 August

    The Indian court dismissed the company's petition and referred it to World Trade Organisation (WTO) regulations which state that countries are allowed to order compulsory licenses which temporarily suspend patents

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics